Diabetes Technology & Therapeutics · 2015 · 16 citations · 13 references
In the newly diagnosed T2DM patients with mild hyperglycemia, PPG is a predominant contributor, whereas the relative contributions of BG gradually increase from mild to severe hyperglycemia and obviously exceed PPG in the T2DM patients with HbA1c levels of >9.0%. This finding implies that the initial pharmacotherapy may target PPG in those patients with mild hyperglycemia and target BG in those patients with severe hyperglycemia.
13
R. C. Turner, Charles Fox, Matthews et al. · The Lancet · 1998 · 8.4K citations
Metabolic Syndrome, Diabetes Management, Diabetes Epidemiology +10
Defining the Relationship Between Plasma Glucose and HbA1c
Curt L. Rohlfing, Hsiao-Mei Wiedmeyer, Randie R. Little et al. · Diabetes Care · 2002 · 984 citations · Full text